{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:19:16Z","timestamp":1791631156788,"version":"4.3.4"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T00:00:00Z","timestamp":1354579200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2012.120","type":"journal-article","created":{"date-parts":[[2012,12,4]],"date-time":"2012-12-04T09:42:20Z","timestamp":1354614140000},"page":"e199-e199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":213,"title":["Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes"],"prefix":"10.1038","volume":"2","author":[{"given":"S J","family":"Sukoff Rizzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S J","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z A","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Beyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Rosenzweig-Lipson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S J","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N J","family":"Brandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,4]]},"reference":[{"key":"BFtp2012120_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/0306-9877(91)90272-Z","volume":"35","author":"RS Smith","year":"1991","unstructured":"Smith RS . The macrophage theory of depression. Med Hypothesis 1991; 35: 298\u2013306.","journal-title":"Med Hypothesis"},{"key":"BFtp2012120_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0278-5846(94)00101-M","volume":"19","author":"M Maes","year":"1995","unstructured":"Maes M . Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19: 11\u201338.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFtp2012120_CR3","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163: 1905\u20131917.","journal-title":"Am J Psychiatry"},{"key":"BFtp2012120_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s11920-007-0061-3","volume":"9","author":"D Warden","year":"2007","unstructured":"Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR . The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep 2007; 9: 449\u2013459.","journal-title":"Curr Psychiatry Rep"},{"key":"BFtp2012120_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1006\/cyto.1997.0238","volume":"9","author":"M Maes","year":"1997","unstructured":"Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H . Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997; 9: 853\u2013858.","journal-title":"Cytokine"},{"key":"BFtp2012120_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-0-585-37970-8_2","volume":"461","author":"M Maes","year":"1999","unstructured":"Maes M . Major depression and activation of the inflammatory response system. Adv Exp Med Biol 1999; 461: 25\u201345.","journal-title":"Adv Exp Med Biol"},{"key":"BFtp2012120_CR7","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.pnpbp.2007.03.004","volume":"31","author":"Y-K Kim","year":"2007","unstructured":"Kim Y-K, Na K-S, Shin K-H, Jung H-Y, Choe S-H, Kim J-B . Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31: 1044\u20131053.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFtp2012120_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","volume":"18","author":"NM Simon","year":"2008","unstructured":"Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH et al. A detailed examination of cytokine abnormalities in major depressive disorder. Eur Neuropsychopharmacol 2008; 18: 230\u2013233.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtp2012120_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446\u2013457.","journal-title":"Biol Psychiatry"},{"key":"BFtp2012120_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.nbd.2009.11.015","volume":"37","author":"JM Loftis","year":"2010","unstructured":"Loftis JM, Huckans M, Morasco BJ . Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis 2010; 37: 519\u2013533.","journal-title":"Neurobiol Dis"},{"key":"BFtp2012120_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pnpbp.2004.11.003","volume":"29","author":"OJ Schiepers","year":"2005","unstructured":"Schiepers OJ, Wichers MC, Maes M . Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 201\u2013217.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFtp2012120_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","volume":"27","author":"CL Raison","year":"2006","unstructured":"Raison CL, Capuron L, Miller AH . Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24\u201331.","journal-title":"Trends Immunol"},{"key":"BFtp2012120_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/brbi.2000.0597","volume":"15","author":"EP Zorrilla","year":"2001","unstructured":"Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A et al. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun 2001; 15: 199\u2013226.","journal-title":"Brain Behav Immun"},{"key":"BFtp2012120_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/15622970701263303","volume":"8","author":"R Mossner","year":"2007","unstructured":"Mossner R, Mikova O, Koutsilieri E, Saoud M, Ehlis AC, Muller N et al. Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry 2007; 8: 141\u2013174.","journal-title":"World J Biol Psychiatry"},{"key":"BFtp2012120_CR15","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","volume":"71","author":"MB Howren","year":"2009","unstructured":"Howren MB, Lamkin DM, Suls J . Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71: 171\u2013186.","journal-title":"Psychosom Med"},{"key":"BFtp2012120_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.biopsych.2009.01.030","volume":"66","author":"D Lindqvist","year":"2009","unstructured":"Lindqvist D, Janelidze S, Hagell P, Erhardt S, Samuelsson M, Minthon L et al. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry 2009; 66: 287\u2013292.","journal-title":"Biol Psychiatry"},{"key":"BFtp2012120_CR17","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.pnpbp.2009.03.020","volume":"33","author":"R Yoshimura","year":"2009","unstructured":"Yoshimura R, Hori H, Ikenouchi-Sugita A, Umene-Nakano W, Ueda N, Nakamura J . Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 722\u2013726.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFtp2012120_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hup.717","volume":"20","author":"AD Basterzi","year":"2005","unstructured":"Basterzi AD, Aydemir C, Kisa C, Aksaray S, Tuzer V, Yazici K et al. IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol 2005; 20: 473\u2013476.","journal-title":"Hum Psychopharmacol"},{"key":"BFtp2012120_CR19","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.4088\/JCP.v67n1114","volume":"67","author":"R Leo","year":"2006","unstructured":"Leo R, Di Lorenzo G, Tesauro M, Razzini C, Forleo GB, Chiricolo G et al. Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. J Clin Psychiatry 2006; 67: 1760\u20131766.","journal-title":"J Clin Psychiatry"},{"key":"BFtp2012120_CR20","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1038\/npp.2011.132","volume":"36","author":"J Hannestad","year":"2011","unstructured":"Hannestad J, Dellagioia N, Bloch M . The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology 2011; 36: 2452\u20132459.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp2012120_CR21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1749-6632.1995.tb32372.x","volume":"762","author":"A S\u0142uzewska","year":"1995","unstructured":"S\u0142uzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K . Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann NY Acad Sci 1995; 762: 474\u2013476.","journal-title":"Ann NY Acad Sci"},{"key":"BFtp2012120_CR22","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jpsychires.2006.05.013","volume":"41","author":"SM O\u2019Brien","year":"2007","unstructured":"O\u2019Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG . Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res 2007; 41: 326\u2013331.","journal-title":"J Psychiatr Res"},{"key":"BFtp2012120_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0304-3940(92)90209-P","volume":"145","author":"S Kent","year":"1992","unstructured":"Kent S, Kelley KW, Dantzer R . Effects of lipopolysaccharide on food-motivated behavior in the rat are not blocked by an interleukin-1 receptor antagonist. Neurosci Lett 1992; 145: 83\u201386.","journal-title":"Neurosci Lett"},{"key":"BFtp2012120_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jneuroim.2008.03.015","volume":"197","author":"S Hayley","year":"2008","unstructured":"Hayley S, Mangano E, Strickland M, Anisman H . Lipopolysaccharide and a social stressor influence behaviour, corticosterone and cytokine levels: divergent actions in cyclooxygenase-2 deficient mice and wild type controls. J Neuroimmunol 2008; 197: 29\u201336.","journal-title":"J Neuroimmunol"},{"key":"BFtp2012120_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O\u2019Connor JC, Freund GG, Johnson RW, Kelley KW . From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46\u201356.","journal-title":"Nat Rev Neurosci"},{"key":"BFtp2012120_CR26","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1073\/pnas.0708092105","volume":"105","author":"JW Koo","year":"2008","unstructured":"Koo JW, Duman RS . IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci USA 2008; 105: 751\u2013756.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp2012120_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1742-2094-7-43","volume":"7","author":"X Fu","year":"2010","unstructured":"Fu X, Zunich SM, O\u2019Connor JC, Kavelaars A, Dantzer R, Kelley KW . Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. J Neuroinflammation 2010; 7: 43.","journal-title":"J Neuroinflammation"},{"key":"BFtp2012120_CR28","doi-asserted-by":"publisher","first-page":"e20719","DOI":"10.1371\/journal.pone.0020719","volume":"6","author":"E Painsipp","year":"2011","unstructured":"Painsipp E, K\u00f6fer MJ, Sinner F, Holzer P . Prolonged depression-like behavior caused by immune challenge: influence of mouse strain and social environment. PLoS One 2011; 6: e20719.","journal-title":"PLoS One"},{"key":"BFtp2012120_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0149-7634(88)80004-6","volume":"12","author":"BL Hart","year":"1988","unstructured":"Hart BL . Biological basis of the behavior of sick animals. Neurosci Biobehav Rev 1988; 12: 123\u2013137.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFtp2012120_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/0165-6147(92)90012-U","volume":"13","author":"S Kent","year":"1992","unstructured":"Kent S, Bluth\u00e9 RM, Kelley KW, Dantzer R . Sickness behavior as a new target for drug development. Trends Pharmacol Sci 1992; 13: 24\u201328.","journal-title":"Trends Pharmacol Sci"},{"key":"BFtp2012120_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1006\/brbi.1995.1013","volume":"9","author":"A Aubert","year":"1995","unstructured":"Aubert A, Vega C, Dantzer R, Goodall G . Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain Behav Immun 1995; 9: 129\u2013148.","journal-title":"Brain Behav Immun"},{"key":"BFtp2012120_CR32","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1749-6632.1998.tb09597.x","volume":"840","author":"R Dantzer","year":"1998","unstructured":"Dantzer R, Bluth\u00e9 RM, Lay\u00e9 S, Bret-Dibat JL, Parnet P, Kelley KW . Cytokines and sickness behavior. Ann NY Acad Sci 1998; 840: 586\u2013590.","journal-title":"Ann NY Acad Sci"},{"key":"BFtp2012120_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.psych.51.1.29","volume":"51","author":"LR Watkins","year":"2000","unstructured":"Watkins LR, Maier SF . The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol 2000; 51: 29\u201357.","journal-title":"Annu Rev Psychol"},{"key":"BFtp2012120_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1749-6632.2001.tb05827.x","volume":"933","author":"R Dantzer","year":"2001","unstructured":"Dantzer R . Cytokine-induced sickness behavior: mechanisms and implications. Ann NY Acad Sci 2001; 933: 222\u2013234.","journal-title":"Ann NY Acad Sci"},{"key":"BFtp2012120_CR35","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/S0889-1591(02)00077-6","volume":"17","author":"KW Kelley","year":"2003","unstructured":"Kelley KW, Bluth\u00e9 RM, Dantzer R, Zhou JH, Shen WH, Johnson RW et al. Cytokine-induced sickness behavior. Brain Behav Immun 2003; 17: S112\u2013S118.","journal-title":"Brain Behav Immun"},{"key":"BFtp2012120_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","volume":"21","author":"R Dantzer","year":"2007","unstructured":"Dantzer R, Kelley KW . Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 2007; 21: 153\u2013160.","journal-title":"Brain Behav Immun"},{"key":"BFtp2012120_CR37","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th edn American Psychiatric Association: Washington, DC, 1994."},{"key":"BFtp2012120_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2165\/00023210-200519020-00002","volume":"19","author":"CL Raison","year":"2005","unstructured":"Raison CL, Demetrashvili M, Capuron L, Miller AH . Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs 2005; 19: 105\u2013123.","journal-title":"CNS Drugs"},{"key":"BFtp2012120_CR39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0006-8993(94)90006-X","volume":"643","author":"S Zalcman","year":"1994","unstructured":"Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H et al. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res 1994; 643: 40\u201349.","journal-title":"Brain Res"},{"key":"BFtp2012120_CR40","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0893-133X(99)00166-9","volume":"22","author":"K Brebner","year":"2000","unstructured":"Brebner K, Hayley S, Zacharko R, Merali Z, Anisman H . Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology 2000; 22: 566\u2013580.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp2012120_CR41","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0306-4522(97)00533-2","volume":"84","author":"TJ Connor","year":"1998","unstructured":"Connor TJ, Song C, Leonard BE, Merali Z, Anisman H . An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience 1998; 84: 923\u2013933.","journal-title":"Neuroscience"},{"key":"BFtp2012120_CR42","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/0006-8993(93)90468-3","volume":"613","author":"MS Oitzl","year":"1993","unstructured":"Oitzl MS, van Oers H, Sch\u00f6bitz B, de Kloet ER . Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. Brain Res 1993; 613: 160\u2013163.","journal-title":"Brain Res"},{"key":"BFtp2012120_CR43","first-page":"R652","volume":"276","author":"MJ Lenczowski","year":"1999","unstructured":"Lenczowski MJ, Bluth\u00e9 RM, Roth J, Rees GS, Rushforth DA, van Dam AM et al. Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. Am J Physiol 1999; 276: R652\u2013R658.","journal-title":"Am J Physiol"},{"key":"BFtp2012120_CR44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbr.2008.05.009","volume":"193","author":"TH Wu","year":"2008","unstructured":"Wu TH, Lin CH . IL-6 mediated alterations on immobile behavior of rats in the forced swim test via ERK1\/2 activation in specific brain regions. Behav Brain Res 2008; 193: 183\u2013191.","journal-title":"Behav Brain Res"},{"key":"BFtp2012120_CR45","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/0031-9384(90)90024-X","volume":"47","author":"LG LeMay","year":"1990","unstructured":"LeMay LG, Vander AJ, Kluger MJ . The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol Behav 1990; 47: 957\u2013961.","journal-title":"Physiol Behav"},{"key":"BFtp2012120_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0024-3205(97)00608-5","volume":"61","author":"K Shizuya","year":"1997","unstructured":"Shizuya K, Komori T, Fujiwara R, Miyahara S, Ohmori M, Nomura J . The influence of restraint stress on the expression of mRNAs for IL-6 and the IL-6 receptor in the hypothalamus and midbrain of the rat. Life Sci 1997; 61: 135\u2013140.","journal-title":"Life Sci"},{"key":"BFtp2012120_CR47","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/S0024-3205(98)00212-4","volume":"62","author":"K Shizuya","year":"1998","unstructured":"Shizuya K, Komori T, Fujiwara R, Miyahara S, Ohmori M, Nomura J . The expressions of mRNAs for interleukin-6 (IL-6) and the IL-6 receptor (IL-6R) in the rat hypothalamus and midbrain during restraint stress. Life Sci 1998; 62: 2315\u20132320.","journal-title":"Life Sci"},{"key":"BFtp2012120_CR48","first-page":"1","volume":"156","author":"MC Audet","year":"2010","unstructured":"Audet MC, Mangano EN, Anisman H . Behavior and pro-inflammatory cytokine variations among submissive and dominant mice engaged in aggressive encounters: moderation by corticosterone reactivity. Front Behav Neurosci 2010; 156: 1\u201312.","journal-title":"Front Behav Neurosci"},{"key":"BFtp2012120_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2009.06.031","volume":"473","author":"LJ Xiu","year":"2010","unstructured":"Xiu LJ, Lin HM, Wei PK . The effect of chronic mild stress on tumor-bearing rats\u2019 behavior and its mechanism. Neurosci Lett 2010; 473: 1\u20134.","journal-title":"Neurosci Lett"},{"key":"BFtp2012120_CR50","doi-asserted-by":"publisher","first-page":"9075","DOI":"10.1523\/JNEUROSCI.1537-11.2011","volume":"31","author":"FJ Monje","year":"2011","unstructured":"Monje FJ, Cabatic M, Divisch I, Kim EJ, Herkner KR, Binder BR et al. Constant darkness induces IL-6-dependent depression-like behavior through the NF-\u03baB signaling pathway. J Neurosci 2011; 31: 9075\u20139083.","journal-title":"J Neurosci"},{"key":"BFtp2012120_CR51","unstructured":"Sukoff Rizzo SJ, Wetzler C, Rosenzweig-Lipson S . Antidepressant induced alterations of submissive behavior in a social competition model in Lewis rats. Society for Neuroscience Meeting Planner 2007 Program No. 334.2 Online."},{"key":"BFtp2012120_CR52","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00213-005-0293-z","volume":"185","author":"RH Ring","year":"2006","unstructured":"Ring RH, Malberg JE, Potestio L, Ping J, Boikess S, Luo B et al. Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology (Berl) 2006; 185: 218\u2013225.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp2012120_CR53","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P . The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985; 85: 367\u2013370.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp2012120_CR54","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/nprot.2009.141","volume":"4","author":"AH Macbeth","year":"2009","unstructured":"Macbeth AH, Edds JS, Young WS . Housing conditions and stimulus females: a robust social discrimination task for studying male rodent social recognition. Nat Protoc 2009; 4: 1574\u20131581.","journal-title":"Nat Protoc"},{"key":"BFtp2012120_CR55","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0304-3940(01)01679-2","volume":"302","author":"M Tomita","year":"2001","unstructured":"Tomita M, Holmana BG, Santoro TJ . Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus. Neurosci Lett 2001; 302: 129\u2013132.","journal-title":"Neurosci Lett"},{"key":"BFtp2012120_CR56","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1365-3083.1995.tb03548.x","volume":"41","author":"C-Y Tsai","year":"2006","unstructured":"Tsai C-Y, Wu T-H, Huang SF, Sun KH, Hsieh SC, Han SH et al. Abnormal splenic and thymic IL-4 and TNF- expression in MRL-lpr\/lpr mice. Scand J Immunol 2006; 41: 157\u2013163.","journal-title":"Scand J Immunol"},{"key":"BFtp2012120_CR57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jneuroim.2008.11.009","volume":"207","author":"HX Gao","year":"2009","unstructured":"Gao HX, Campbell SR, Cui MH, Zong P, Hee-Hwang J, Gulinello M et al. Depression is an early disease manifestation in lupus-prone MRL\/lpr mice. J Neuroimmunol 2009; 207: 45\u201356.","journal-title":"J Neuroimmunol"},{"key":"BFtp2012120_CR58","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0361-9230(97)00107-X","volume":"44","author":"B Saki\u0107","year":"1997","unstructured":"Saki\u0107 B, Szechtman H, Braciak T, Richards C, Gauldie J, Denburg JA . Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res Bull 1997; 44: 155\u2013165.","journal-title":"Brain Res Bull"},{"key":"BFtp2012120_CR59","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/sj.mp.4001457","volume":"9","author":"JF Cryan","year":"2004","unstructured":"Cryan JF, Mombereau C . In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 2004; 9: 326\u2013357.","journal-title":"Mol Psychiatry"},{"key":"BFtp2012120_CR60","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.nbd.2006.05.001","volume":"23","author":"S Chourbaji","year":"2006","unstructured":"Chourbaji S, Urani A, Inta I, Sanchis-Segura C, Brandwein C, Zink M et al. IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiol Dis 2006; 23: 587\u2013594.","journal-title":"Neurobiol Dis"},{"key":"BFtp2012120_CR61","doi-asserted-by":"publisher","first-page":"207504","DOI":"10.1155\/2011\/207504","volume":"2011","author":"M Gulinello","year":"2011","unstructured":"Gulinello M, Putterman C . The MRL\/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus. J Biomed Biotechnol 2011; 2011: 207504.","journal-title":"J Biomed Biotechnol"},{"key":"BFtp2012120_CR62","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1073\/pnas.90.5.1756","volume":"90","author":"M Adachi","year":"1993","unstructured":"Adachi M, Watanabe-Fukunaga R, Nagata S . Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA 1993; 90: 1756\u20131760.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFtp2012120_CR63","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/ncprheum0622","volume":"3","author":"RD Strous","year":"2007","unstructured":"Strous RD, Shoenfeld Y . Behavioral changes in systemic lupus erythematosus are of an autoimmune nature. Nat Clin Pract Rheumatol 2007; 3: 592\u2013593.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"BFtp2012120_CR64","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/art.22451","volume":"56","author":"H Fragoso-Loyo","year":"2007","unstructured":"Fragoso-Loyo H, Richaud-Patin Y, Orozco-Narv\u00e1ez A, D\u00e1vila-Maldonado L, Atisha-Fregoso Y, Llorente L et al. Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum 2007; 56: 1242\u20131250.","journal-title":"Arthritis Rheum"},{"key":"BFtp2012120_CR65","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/art.1780210909","volume":"21","author":"FJ Dixon","year":"1978","unstructured":"Dixon FJ, Andrews BS, Eisenberg RA, McConahey PJ, Theofilopoulos AN, Wilson CB . Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice. Arthritis Rheum 1978; 21: 64\u201367.","journal-title":"Arthritis Rheum"},{"key":"BFtp2012120_CR66","doi-asserted-by":"crossref","first-page":"23286","DOI":"10.1016\/S0021-9258(17)31651-4","volume":"69","author":"LD Ward","year":"1994","unstructured":"Ward LD, Howlett GJ, Discolo G, Yasukawa K, Hammacher A, Moritz RL et al. High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J Biol Chem 1994; 69: 23286\u201323289.","journal-title":"J Biol Chem"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/tp2012120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/tp2012120","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp2012120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T16:44:58Z","timestamp":1672937098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp2012120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,4]]},"references-count":66,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12]]}},"alternative-id":["BFtp2012120"],"URL":"https:\/\/doi.org\/10.1038\/tp.2012.120","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,4]]},"assertion":[{"value":"5 October 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SJSR, SJN, ZAH, MB, SR-L and NJB were full time-employees of Pfizer (formerly Wyeth Research) at the inception of this work and have no conflict of interest. SJSR conducted this work as part of her doctoral thesis through University College London, which was fully funded by Pfizer (formerly Wyeth Research) under the direction of her thesis advisor Dr Stephen J Moss. SJM received compensation as a member of the scientific advisory board of Pfizer (formerly Wyeth) and has consulted for GSK, Sepracor and SAGE therapeutics. SR-L is currently owner of IVS Pharma. NJB is currently employed by Astra Zeneca.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}